OTC Markets OTCQB - Delayed Quote USD

Marvel Biosciences Corp. (MBCOF)

Compare
0.0708
0.0000
(0.00%)
As of April 3 at 4:00:00 PM EDT. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Cost of Revenue
1,144.7660
--
887.5160
1,377.1600
613.0990
Gross Profit
-1,144.7660
--
-887.5160
-1,377.1600
-613.0990
Operating Expense
1,182.2220
--
1,360.6690
1,171.1190
485.0430
Operating Income
-2,326.9880
--
-2,248.1850
-2,548.2790
-1,098.1420
Net Non Operating Interest Income Expense
-3.2140
--
-38.4220
-1.5490
-1.7290
Other Income Expense
--
--
-4.7820
-4.3110
-1,939.4750
Pretax Income
-2,340.1330
--
-2,291.3890
-2,554.1390
-3,039.3460
Net Income Common Stockholders
-1,410.0260
-1,650.0790
-2,291.3890
-2,554.1390
-3,039.3460
Diluted NI Available to Com Stockholders
-1,410.0260
-1,650.0790
-2,291.3890
-2,554.1390
-3,039.3460
Basic EPS
-0.04
-0.04
-0.06
-0.08
-0.17
Diluted EPS
-0.04
-0.04
-0.06
-0.08
-0.17
Basic Average Shares
41,213.8270
39,963.8270
39,660.4780
32,758.8340
17,697.1660
Diluted Average Shares
41,213.8270
39,963.8270
39,660.4780
32,758.8340
17,697.1660
Total Expenses
2,326.9880
--
2,248.1850
2,548.2790
1,098.1420
Net Income from Continuing & Discontinued Operation
-1,410.0260
-1,650.0790
-2,291.3890
-2,554.1390
-3,039.3460
Normalized Income
-1,450.2939
-1,650.0790
-2,291.3890
-2,549.8280
-1,134.8710
Interest Income
--
--
--
--
0.2390
Interest Expense
129.0580
113.9770
38.4220
--
--
Net Interest Income
-3.2140
--
-38.4220
-1.5490
-1.7290
EBIT
-2,326.9880
--
-2,256.7980
-2,554.1390
-1,098.1420
EBITDA
-2,326.8740
--
-2,256.7980
-2,553.9870
-1,097.9570
Reconciled Cost of Revenue
1,144.7660
--
887.5160
1,377.1600
613.0990
Reconciled Depreciation
0.1140
--
--
0.1520
0.1850
Net Income from Continuing Operation Net Minority Interest
-1,410.0260
-1,650.0790
-2,291.3890
-2,554.1390
-3,039.3460
Total Unusual Items Excluding Goodwill
47.3740
--
-4.7820
-4.3110
-1,904.4750
Total Unusual Items
47.3740
--
-4.7820
-4.3110
-1,904.4750
Normalized EBITDA
-2,316.9430
--
-2,252.0160
-2,549.6760
806.5180
Tax Rate for Calcs
0.0002
0.0002
0.0004
--
--
Tax Effect of Unusual Items
7.1061
--
--
--
--
7/31/2021 - 6/23/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IVBIY Innovent Biologics Inc.
22.29
0.00%
 
TSBX Turnstone Biologics Corp.
0.3797
+0.73%
 
DRTS Alpha Tau Medical Ltd.
2.4500
-2.00%
 
MAZE Maze Therapeutics, Inc.
9.20
-1.32%
 
THAR Tharimmune, Inc.
1.2106
-5.42%
 
VANI Vivani Medical, Inc.
0.9400
-5.05%
 
HCWB HCW Biologics Inc.
0.2414
+1.13%
 
CNTA Centessa Pharmaceuticals plc
12.27
-6.05%
 
COGT Cogent Biosciences, Inc.
4.9350
-7.40%
 
FBLG FibroBiologics, Inc.
0.8740
-0.11%